A maturity model for process data analytics in biopharmaceutical manufacturing

Thesis: S.M. in Engineering and Management, Massachusetts Institute of Technology, System Design and Management Program, February, 2021

Bibliographic Details
Main Author: Egaña Tomic, Tomas C.
Other Authors: Massachusetts Institute of Technology. Engineering and Management Program.
Format: Thesis
Language:eng
Published: Massachusetts Institute of Technology 2021
Subjects:
Online Access:https://hdl.handle.net/1721.1/132884
_version_ 1811080759908237312
author Egaña Tomic, Tomas C.
author2 Massachusetts Institute of Technology. Engineering and Management Program.
author_facet Massachusetts Institute of Technology. Engineering and Management Program.
Egaña Tomic, Tomas C.
author_sort Egaña Tomic, Tomas C.
collection MIT
description Thesis: S.M. in Engineering and Management, Massachusetts Institute of Technology, System Design and Management Program, February, 2021
first_indexed 2024-09-23T11:36:24Z
format Thesis
id mit-1721.1/132884
institution Massachusetts Institute of Technology
language eng
last_indexed 2024-09-23T11:36:24Z
publishDate 2021
publisher Massachusetts Institute of Technology
record_format dspace
spelling mit-1721.1/1328842022-10-04T19:05:34Z A maturity model for process data analytics in biopharmaceutical manufacturing Egaña Tomic, Tomas C. Massachusetts Institute of Technology. Engineering and Management Program. System Design and Management Program. Massachusetts Institute of Technology. Engineering and Management Program Engineering and Management Program. System Design and Management Program. Thesis: S.M. in Engineering and Management, Massachusetts Institute of Technology, System Design and Management Program, February, 2021 Cataloged from the official version of thesis. Page 148 blank. Includes bibliographical references (pages 139-147). The Biopharmaceutical industry continues to add a record number of life-saving biological therapies every year, which builds up pressure to make their manufacturing processes faster, more consistent, and more productive. Increased digitalization is expected to address these needs by means of new capabilities related to the analysis of the data collected in the manufacturing process (a.k.a. process data analytics). The objective of this work is to research a framework with which to assess the ability of a Biopharmaceutical company to exploit process data analytics in drug substance manufacturing of monoclonal antibodies. A comprehensive view of the potential benefits of process data analytics is provided, as well as a detailed account of the improvements required to realize those benefits. The framework was built using the published information of analytics use cases, the opinions of experienced practitioners of four major biopharmaceutical companies, and other guidelines built to address similar topics in other industries. Throughout the process, a detailed account of the complexities involved in the deployment of process data analytics was captured and explained. Additionally, four approaches driving the value of analytics for biopharmaceutical processing were identified and used to classify the different use cases. The result is a maturity model of the manufacturing site that describes four archetypical states of process data analytics implementation. They are characterized in terms of the mechanics of value creation and the requirements from informational technology (IT), operational technology (OT), and external sources of information. This model provides the basis upon which biopharmaceutical manufacturers or industry consortiums can further specify its content and generate an assessment tool to guide their manufacturing strategies. by Tomas C. Egaña Tomic. S.M. in Engineering and Management S.M.inEngineeringandManagement Massachusetts Institute of Technology, System Design and Management Program 2021-10-08T17:10:30Z 2021-10-08T17:10:30Z 2021 2021 Thesis https://hdl.handle.net/1721.1/132884 1263357244 eng MIT theses may be protected by copyright. Please reuse MIT thesis content according to the MIT Libraries Permissions Policy, which is available through the URL provided. http://dspace.mit.edu/handle/1721.1/7582 148 pages application/pdf Massachusetts Institute of Technology
spellingShingle Engineering and Management Program.
System Design and Management Program.
Egaña Tomic, Tomas C.
A maturity model for process data analytics in biopharmaceutical manufacturing
title A maturity model for process data analytics in biopharmaceutical manufacturing
title_full A maturity model for process data analytics in biopharmaceutical manufacturing
title_fullStr A maturity model for process data analytics in biopharmaceutical manufacturing
title_full_unstemmed A maturity model for process data analytics in biopharmaceutical manufacturing
title_short A maturity model for process data analytics in biopharmaceutical manufacturing
title_sort maturity model for process data analytics in biopharmaceutical manufacturing
topic Engineering and Management Program.
System Design and Management Program.
url https://hdl.handle.net/1721.1/132884
work_keys_str_mv AT eganatomictomasc amaturitymodelforprocessdataanalyticsinbiopharmaceuticalmanufacturing
AT eganatomictomasc maturitymodelforprocessdataanalyticsinbiopharmaceuticalmanufacturing